Skip to content

DOKTERS MARCHAL - DE VADDER

Active
Private limited companyfounded 2006active for 20 yearsErfstraat 42, 2861 Sint-Katelijne-Waver, BelgiumKBO/BCE: BE 0879.679.835

From the official registers: KBO 20 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DOKTERS MARCHAL - DE VADDER has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3.4m and a net result of €525,935. Equity has been growing by about 9% per year since 2018. Its solvency ranks better than 95% of 3,024 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 21-02-2006 Normal situation
Activity
Specialist medical practice NACE 86220and 1 other
Establishment units
2.208.957.046 2861 Sint-Katelijne-Waver, since 21-02-2006
2.208.956.947 2840 Rumst, since 15-06-2011
Financial year end
31 December
Peppol
Reachable since 10-09-2025

Board and ownership

Board
Shareholders

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€788,355
▲ 18.1%
Turnover
≈ €1.5m
estimated
Profit
€525,935
▲ 26.0%
Equity
€3.4m
▲ 8.3%
Total assets
€3.5m
▲ 7.6%
Filed on 14-07-2026, 17 days before the deadlineat the National Bank
Score breakdownlowers riskFigures for financial year 2025 (filed on 14-07-2026)Size: total assets €3.5mSector: Human health activities (NACE 86)Equity €3.4m (97.5% of total assets)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 61% of small companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 97.5% of total assets
Liquidity 58-7
short-term debt 2.5% · cash 6.7%
Profitability 88+3
return on assets 15.2%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (1,078 companies, NACE 86, small)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025highest value 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €320,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 36.35 (29.68 in 2024), above the usual 1.5. Short-term debt is 2.5% and cash 6.7% of total assets. 2.5% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small). It does better than 77% of them on solvency, 43% on liquidity, 74% on profitability and 50% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Figures for financial year 2025 (filed on 14-07-2026)
NBB · annual accounts
lowers risk · Size: total assets €3.5m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Equity €3.4m (97.5% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-07-2026, 17 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
17 days early
2024
16 days early
2023
12 days early
2022
25 days late
2021
6 days late
2020
11 days late
2019
38 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 6 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 20 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 95% of companies in human healthsector median 59.1% · 3,024 companies 97.5% View
  • Positive: 8 profitable years in a rowprofit 2025: €525,935 8 years View
  • Positive: Result rose in 2025from €417,293 to €525,935 ▲ 26.0% View

Comparable companies

These companies have the same main activity as DOKTERS MARCHAL - DE VADDER: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €3m and €3.5m, founded between 2003 and 2008.

CompanyTotal assetsGross margin
DOKTERS MARCHAL - DE VADDER Sint-Katelijne-Waver€3.5m€0.8m
DR. VERMEERSCH PAUL Hove€3.2m€0.8m
Dr. Philip Claessens - Cardiologie Schilde€3.3m€0.8m
DOKTER FABRICE LOCKEFEER Kontich€3.0m€0.8m
DOKTER WIM VOLDERS Brasschaat€3.0m€0.8m
DR. BRESSELEERS DIRK - CARDIOLOOG Kapellen€3.0m€0.8m
Oogkliniek Dr. K. Vanhoucke Mol€3.5m€0.7m
Full comparison

Documents

Annual accounts at the NBB

All 20 annual accounts

Articles and registers

Key facts about DOKTERS MARCHAL - DE VADDER

What is the company number of DOKTERS MARCHAL - DE VADDER?
The company number of DOKTERS MARCHAL - DE VADDER is 0879.679.835. The VAT number is the same number with BE in front: BE 0879.679.835.
Where is DOKTERS MARCHAL - DE VADDER based?
The registered office is at Erfstraat 42, 2861 Sint-Katelijne-Waver.Company details
What does DOKTERS MARCHAL - DE VADDER do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DOKTERS MARCHAL - DE VADDER?
The legal form of DOKTERS MARCHAL - DE VADDER is Private limited company (BV).
When was DOKTERS MARCHAL - DE VADDER founded?
DOKTERS MARCHAL - DE VADDER was founded on 21-02-2006.
Is DOKTERS MARCHAL - DE VADDER still active?
Yes, DOKTERS MARCHAL - DE VADDER is an active enterprise in the KBO register.
What is the turnover of DOKTERS MARCHAL - DE VADDER?
The turnover in financial year 2025 is ≈ €1.5m. This figure is estimated from the gross margin of €788,355 and 40 comparable companies (NACE 862). It probably lies between €1.0m and €2.4m.Financials
Is DOKTERS MARCHAL - DE VADDER profitable?
In financial year 2025, DOKTERS MARCHAL - DE VADDER made a profit of €525,935.
Where can I find the annual accounts of DOKTERS MARCHAL - DE VADDER?
DOKTERS MARCHAL - DE VADDER filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of DOKTERS MARCHAL - DE VADDER due?
DOKTERS MARCHAL - DE VADDER must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.